The Cost of Keeping Schools Safe

In the rush to develop a vaccine or treatment for Covid-19, drug companies are fast-tracking clinical trials. But those trials have a major diversity problem. Participants in major drug trials range from 70 percent to 89 percent white. This is a big problem, considering it’s a di ...  Show more

In the fight against COVID-19, so many are pinning their hopes on a vaccine. But how long will it take? Russia’s super-fast-tracked COVID-19 one is technically the first in the world. But the first vaccine may not be the best one. And even with other vaccine trials underway aroun ...  Show more

Several vaccine companies have announced promising early evidence that their vaccines are effective at preventing symptoms of a coronavirus infection. So what comes next? CNN Chief Medical Correspondent Dr. Sanjay Gupta talks to vaccine creator and virology and immunology expert, ...  Show more

Long Covid can ruin lives, and scientists are striving to understand the condition and beginning to get some early clues about possible treatments. While there are still more questions than answers, though, many have turned online for help. But could what they find there sometime ...  Show more

Earlier this spring, doctors around the country began to worry that fear of Covid-19 was keeping their patients away. Now, we’re starting to see the consequences of that. Today, CNN’s Chief Medical Correspondent Dr. Sanjay Gupta talks to Dr. Michelle Kittleson, a cardiologist in ...  Show more

Everybody hopes that the new super-charged Omicron variant of coronavirus will be less severe, but even if it is, it’s spreading so fast and infecting so many people, health services around the world could still buckle under the strain.Two years into the pandemic, Claudia Hammond ...  Show more